Cutting edge: adenovirus E19 has two mechanisms for affecting class I MHC expression.

Viral strategies for immune evasion include inhibition of various steps in the class I MHC assembly pathway. Here, we demonstrate that adenovirus produces one gene product with a dual function in this regard. It is well established that adenovirus E19 binds class I molecules and retains them in the endoplasmic reticulum (ER). However, E19 also delays the expression of class I alleles to which it cannot tightly bind. Here, we show that E19 binds TAP and acts as a tapasin inhibitor, preventing class I/TAP association. DeltaE19, an E19 mutant lacking the ER-retention signal, delays maturation of class I molecules, indicating that E19's inhibition of class I/TAP interaction is sufficient to delay class I expression. These data identify tapasin inhibition as a novel mechanism of viral immune evasion and suggest that, through this secondary mechanism, adenovirus can affect Ag presentation by MHC alleles that it can only weakly affect by direct retention.

[1]  J. Trowsdale,et al.  Antigen presentation: Coming out gracefully , 1998, Current Biology.

[2]  H. Ploegh.  Viral strategies of immune evasion. , 1998, Science.

[3]  A. McMichael,et al.  TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide , 1998, Current Biology.

[4]  C. Ware,et al.  The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis , 1997, Journal of virology.

[5]  R. Tampé,et al.  A critical role for tapasin in the assembly and function of multimeric MHC class I-TAP complexes. , 1997, Science.

[6]  F. Brodsky,et al.  Localization of class I histocompatibility molecule assembly by subfractionation of the early secretory pathway. , 1997, Human immunology.

[7]  J. Solheim,et al.  Prominence of beta 2-microglobulin, class I heavy chain conformation, and tapasin in the interactions of class I heavy chain with calreticulin and the transporter associated with antigen processing. , 1997, Journal of immunology.

[8]  P. Cresswell,et al.  Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. , 1996, Immunity.

[9]  R. Demars,et al.  Novel allele-specific, post-translational reduction in HLA class I surface expression in a mutant human B cell line. , 1994, Journal of immunology.

[10]  P. Cresswell,et al.  MHC class l/β2-microglobulin complexes associate with TAP transporters before peptide binding , 1994, Nature.

[11]  P. Cresswell,et al.  Association of human class I MHC alleles with the adenovirus E3/19K protein. , 1994, Journal of immunology.

[12]  R. Tripp,et al.  Deletion mutation analysis of the adenovirus type 2 E3-gp19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes , 1993, Journal of virology.

[13]  P. Cresswell,et al.  Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer , 1992, Nature.

[14]  J. Yewdell,et al.  Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation , 1991, The Journal of experimental medicine.

[15]  W. Wold,et al.  Region E3 of adenovirus: a cassette of genes involved in host immunosurveillance and virus-cell interactions. , 1991, Virology.

[16]  M. Jackson,et al.  Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. , 1990, The EMBO journal.

[17]  J. Yewdell,et al.  Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. , 1990, Science.

[18]  R. Demars,et al.  Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. , 1989, Journal of immunology.

[19]  J. Levin,et al.  Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses. , 1987, Virology.

[20]  H. Burgert,et al.  The E3/19K protein of adenovirus type 2 binds to the domains of histocompatibility antigens required for CTL recognition. , 1987, The EMBO journal.

[21]  P. A. Peterson,et al.  Reduced allorecognition of adenovirus-2 infected cells. , 1987, Journal of immunology.

[22]  J. Maryanski,et al.  "E3/19K" protein of adenovirus type 2 inhibits lysis of cytolytic T lymphocytes by blocking cell-surface expression of histocompatibility class I antigens. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. A. Peterson,et al.  Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance , 1985, Cell.

[24]  H. Burgert,et al.  An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens , 1985, Cell.

[25]  M. Katze,et al.  An adenovirus glycoprotein binds heavy chains of class I transplantation antigens from man and mouse , 1982, Nature.

[26]  C. Barnstable,et al.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis , 1978, Cell.